Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma.

Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma.

Biomedical imaging techniques such as skeletal survey and (18)F-fluorodeoxyglucose (FDG)/Positron Emission Tomography (PET) are frequently used to diagnose and stage multiple myeloma (MM) patients. However, skeletal survey has limited sensitivity as it can detect osteolytic lesions only after 30-50%...

Full description

Bibliographic Details
Main Authors: Deepti Soodgupta, Michelle A Hurchla, Majiong Jiang, Alexander Zheleznyak, Katherine N Weilbaecher, Carolyn J Anderson, Michael H Tomasson, Monica Shokeen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3568146?pdf=render

Internet

http://europepmc.org/articles/PMC3568146?pdf=render

Similar Items